Epidemiology of hypertrophic cardiomyopathy-related death: Revisited in a large non-referral-based patient population

Circulation

Volumn 102, Issue 8, 2000, Pages 858-864

  Maron, Barry J ^a   Olivotto, Iacopo ^e   Spirito, Paolo ^b   Casey, Susan A ^a   Bellone, Pietro ^c   Gohman, Thomas E ^a   Graham, Kevin J ^a   Burton, David A ^d   Cecchi, Franco ^e  

^a MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

^b GALLIERA HOSPITAL   (Italy)

^c SANTA CORONA HOSPITAL   (Italy)

^d Children's Heart Clinic   (United States)

^e CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

Cardiomyopathy; Death, sudden; Heart failure

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CHILD; FAMILY HISTORY; FEMALE; HEART ARRHYTHMIA; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; STROKE; SUDDEN DEATH;

EID: 0034702926     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.102.8.858     Document Type: Article

References (44)

1. Hypertrophic cardiomyopathy
2. Hypertrophic cardiomyopathy: Clinical spectrum and treatment
3. The management of hypertrophic cardiomyopathy
4. Hypertrophic cardiomyopathy: Interrelation of clinical manifestations, pathophysiology, and therapy (parts I and II)
5. Hypertrophic cardiomyopathy: The importance of the site and extent of hypertrophy- A review
6. Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatient population
7. Clinical course of hypertrophic cardiomyopathy in a regional United States cohort
8. Natural history of hypertrophic cardiomyopathy: A population-based study, 1976 through 1990
9. Impact of laboratory molecular diagnosis on contemporary diagnostic criteria for genetically transmitted cardiovascular diseases: Hypertrophic cardiomyopathy, long-QT syndrome, and Marfan syndrome
10. Asymmetrical hypertrophy of the heart in young adults
11. Idiopathic hypertrophic subaortic stenosis: Clinical analysis of 126 patients with emphasis on the natural history
12. The natural (and unnatural) history of hypertrophic obstructive cardiomyopathy
13. Analysis of symptomatic course and prognosis and treatment of hypertrophic obstructive cardiomyopathy
14. Predictors of sudden cardiac death in hypertrophic cardiomyopathy
15. Prognosis and mortality of hypertrophic obstructive cardiomyopathy
16. Hypertrophic cardiomyopathy: An important cause of sudden death
17. Prognosis of hypertrophic cardiomyopathy: Role of age and clinical, electrocardiographic and hemodynamic features
18. Idiopathic hypertrophic subaortic stenosis in the young
19. Asymmetric septal hypertrophy in childhood
20. Sudden death in hypertrophic cardiomyopathy: Assessment of patients at high risk
21. Sudden death in hypertrophic cardiomyopathy: Profile of 78 patients
22. Impact of patient selection biases on the perception of hypertrophic cardiomyopathy and its natural history
23. Hypertrophic cardiomyopathy in Tuscany: Clinical course and outcome in an unselected regional population
24. Infective endocarditis in hypertrophic cardiomyopathy: Prevalence incidence and indications for antibiotic prophylaxis
25. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: Morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients
26. Patterns and significance of the distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: A wide-angle, two-dimensional echocardiographic study of 125 patients
27. Utility of continuous wave Doppler echocardiography in the noninvasive assessment of left ventricular outflow tract pressure gradient in patients with hypertrophic cardiomyopathy
28. Echocardiographic measurements in normal subjects from infancy to old age
29. Hypertrophic cardiomyopathy: A discussion of nomenclature
30. Both aborted sudden cardiac death and end-stage phase in hypertrophic cardiomyopathy
31. Implications of left ventricular remodeling in hypertrophic cardiomyopathy
32. Clinicopathologic features of hypertrophic cardiomyopathy managed by cardiac transplantation
33. Classification of subtype of acute ischemic stroke: Definitions for use in a multicenter clinical trial
34. Relation between extent of left ventricular hypertrophy and occurrence of sudden cardiac death in hypertrophic cardiomyopathy
35. Efficacy of the implantable cardioverter-defibrillator for the prevention of sudden death in hyperophic cardiomyopathy
36. Improved survival with an implanted defibrillator in patients with coronary artery disease at high risk for ventricular arrhythmia
37. Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia
38. Prognostic value of nonsustained ventricular tachycardia and the potential role of amiodarone treatment in hypertrophic cardiomyopathy: Assessment in an unselected non-referral based patient population
39. Hypertrophic cardiomyopathy, myocarditis and other myopericardial diseases, and mitral valve prolapse: Task Force 3
40. Sudden death in young competitive athletes: Clinical, demographic and pathological profiles
41. Nontraumatic sports death in high school and college athletes
42. Sudden death in young athletes
43. 26th Bethesda Conference: Recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities
44. Screening for hypertrophic cardiomyopathy in young athletes